Monensin
-
Identifiers
CAS number
17090-79-8Molecular formula
C36H62O11SMILES
CC[C@]1(CC[C@@H](O1)[C@@]2(CC[C@@]3(O2)C[C@@H]([C@H]([C@H](O3)[C@@H](C)[C@H]([C@H](C)C(=O)O)OC)C)O)C)[C@H]4[C@H](C[C@@H](O4)[C@@H]5[C@H](C[C@H]([C@@](O5)(CO)O)C)C)C
Safety labels
Acute Toxic
Irritant
Health -
Odor profile
Fragrance Odorless 50.45% Cooling 29.66% Mint 28.4% Milky 22.49% Woody 21.21% Sweet 19.74% Creamy 19.27% Lactonic 18.72% Savory 18.2% Fresh 16.23% Flavor Bitter 41.14% Fatty 30.09% Sweet-like 23.71% Odorless 23.42% Metallic 22.98% Cedarleaf 21.83% Minty 21.53% Bouillon 21.26% Cauliflower 21.09% Mentholic 20.88% Odor impact est.
Low -
Properties
XLogP3-AA
4.2pKa est.
5.85 (weak acid)Molecular weight
670.9 g/molVapor pressure est.
- hPa @ 20°C
- hPa @ 25°C
Evaporation rate
Ultra fastBoiling point est.
222°CMelting point expt.
- MP: 103-105 °C /Monensin monohydrate/
Flash point
- 190.84 ˚C est.
Solubility expt.
- Slightly soluble in water
- Very soluble in organic solvents
- Soluble in nonpolar organic solvents
-
Synonyms
- monensin
- monensin A
- Monensic acid
- Monensina
- Monensinum
- 17090-79-8
- Elancoban
- Monelan
- Rumensin 90
- A 3823A
- Coban (as sodium salt)
- Rumensin (as sodium salt)
- Lilly 673140
- A-3823A
- 906O0YJ6ZP
- ATCC 15413
- DTXSID4048561
- CHEBI:27617
- (2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-{(2S,2'R,3'S,5R,5'R)-2-ethyl-5'-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl]-3'-methyloctahydro-2,2'-bifuran-5-yl}-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]-3-methoxy-2-methylpentanoic acid
- 1,6-Dioxaspiro(4.5)decane-7-butyric acid, 2-(5-ethyltetrahydro-5-(tetrahydro-3-methyl-5-(tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl)-2-furyl)-2-furyl)-9-hydroxy-beta-methoxy-alpha,gamma,2,8-tetramethyl-
- 4-(2-(2-ETHYL-3'-METHYL-5'-(TETRAHYDRO-6-HYDROXY-6-HYDROXYMETHYL-3,5-DIMETHYLPYRAN-2-YL)PERHYDRO-2,2'-BIFURAN-5-YL)-9-HYDROXY-2,8-DIMETHYL-1,6-DIOXASPIRO(4.5)DEC-7-YL)3-METHOXY-2-METHYLPENTANOIC ACID
- Monensin Granulated
- (2S,3R,4S)-4-((2S,5R,7S,8R,9S)-2-((2R,5S)-5-ethyl-5-((2R,3S,5R)-5-((2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl)-3-methyloxolan-2-yl)oxolan-2-yl)-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro(4.5)decan-9-yl)-3-methoxy-2-methylpentanoic acid
- (2S,3R,4S)-4-((2S,5R,7S,8R,9S)-2-((2S,2'R,3'S,5R,5'R)-2-ethyl-5'-((2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)-3'-methyloctahydro-2,2'-bifuran-5-yl)-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro(4.5)dec-7-yl)-3-methoxy-2-methylpentanoic acid
- (2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoic acid
- Coxidin 90
- Monovet 90
- Coban 90
- CycleGuard and Monovet
- RefChem:57076
- GlyTouCan:G49969XG
- DTXCID7028190
- monensin Type A medicated article
- G49969XG
- 241-154-0
- Pasture Gainer Block 20 R350, Pasture Gainer Block 20 R350 No SE, Pasture Gainer Block 37 R350, Pasture Gainer Block 37 R350 No SE
- Monensin (INN)
- MONENSIN [INN]
- Monensinum [INN-Latin]
- Monensina [INN-Spanish]
- UNII-906O0YJ6ZP
- Monensine
- HSDB 7031
- Monensin [USAN:USP:INN:BAN]
- 2-(5-ETHYLTETRAHYDRO-5-(TETRAHYDRO-3-METHYL-5-(TETRAHYDRO-6-HYDROXY-6-(HYDROXYMETHYL)-3,5-DIMETHYL-2H-PYRAN-2-YL)-2-FURYL)-2-FURYL)-9-HYDROXY-.BETA.-METHOXY-.ALPHA.,.GAMMA.,2,8-TETRAMETHYL-1,6-DIOXASPIRO(4.5)DECANE-7-BUTYRIC ACID
- 2-[5-Ethyltetrahydro-5-[tetrahydro-3-methyl-5-[tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl]-2-furyl]-2-furyl]-9-hydroxy-.beta.-methoxy-.alpha.,.gamma.,2,8-tetramethyl-1,6-dioxaspiro[4.5]decane-7-butyric acid
- EINECS 241-154-0
- MFCD00799192
- MONENSIN [HSDB]
- MONENSIN [USAN]
- MONENSIN [MI]
- Prestwick3_000748
- MONENSIN [MART.]
- SCHEMBL55367
- BSPBio_000736
- Elancoban [veterinary] (TN)
- MONENSIN [GREEN BOOK]
- BPBio1_000810
- CHEMBL256105
- orb1710412
- MONENSIN [USP IMPURITY]
- MONENSIN [USP MONOGRAPH]
- GTPL14126
- HY-N4302
- AKOS015964837
- DB11430
- FM31903
- E714
- Stereoisomer of 2-(2-ethyloctahydro-3'-methyl-5'-(tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl)(2,2'-bifuran-5-yl))-9-hydroxy-beta-methoxy-alpha,gamma,2,8-tetramethyl-1,6-dioxaspiro(4.5)decan-7-butanoic acid
- SY248013
- CS-0032703
- NS00000169
- C06693
- D08228
- Q3493048
- SR-05000013702-2
- BRD-K55375480-236-03-0
- (2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-3-methoxy-2-methylpentanoic acid
- (2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-{(2S,2'R,3'S,5R,5'R)-2-Ethyl-5'-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3'-methyl[2,2'-bioxolan]-5-yl}-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-3-methoxy-2-methylpentanoic acid
- (2S,3R,4S)-4-[(3S,5R,7S,8R,9S)-3-[(2R,5S)-5-ethyl-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-tetrahydropyran-2-yl]-3-methyl-tetrahydrofuran-2-yl]tetrahydrofuran-2-yl]-7-hydroxy-3,8-dimethyl-4,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methyl-pentanoic acid
- 2-(2-ETHYLOCTAHYDRO-3'-METHYL-5'-(TETRAHYDRO-6-HYDROXY-6-(HYDROXYMETHYL)-3,5-DIMETHYL-2H-PYRAN-2-YL)(2,2'-BIFURAN-5-YL))-9-HYDROXY-.BETA.-METHOXY-.ALPHA.,.GAMMA.,2,8-TETRAMETHYL-1,6-DIOXASPIRO(4.5)DECAN-7-BUTANOIC ACID
- 17090-79-8
-
Applications
Monensin (CAS 17090-79-8) is a polyether ionophore antibiotic used primarily in animal production as a feed additive to prevent coccidiosis in poultry and to improve feed efficiency in cattle, sheep, and other ruminants; it is typically supplied as premixes or medicated feeds under veterinary supervision. In practice, it acts as a coccidiostat and rumen modifier, modulating fermentation to enhance performance while controlling parasite loads. Beyond production agriculture, it is used in veterinary research and formulation development as an ionophore antibiotic tool to study membrane ion transport. Its use is regulated and limited by local regulations and formulation specifications, and it is not intended for human use.
gpt-5-nano
-
Solubility @25˚C
Solvent Solubility (g/L) ethanol 159.58 methanol 331.95 isopropanol 54.32 water 1.29 ethyl acetate 73.95 n-propanol 129.0 acetone 124.27 n-butanol 60.15 acetonitrile 37.41 DMF 490.89 toluene 16.83 isobutanol 49.47 1,4-dioxane 140.41 methyl acetate 74.8 THF 390.28 2-butanone 103.16 n-pentanol 38.79 sec-butanol 41.31 n-hexane 0.48 ethylene glycol 69.81 NMP 656.75 cyclohexane 0.63 DMSO 498.99 n-butyl acetate 27.05 n-octanol 14.5 chloroform 142.34 n-propyl acetate 33.84 acetic acid 574.02 dichloromethane 135.9 cyclohexanone 140.31 propylene glycol 107.32 isopropyl acetate 40.53 DMAc 472.75 2-ethoxyethanol 209.03 isopentanol 25.18 n-heptane 0.43 ethyl formate 77.18 1,2-dichloroethane 62.7 n-hexanol 20.47 2-methoxyethanol 410.04 isobutyl acetate 19.03 tetrachloromethane 14.55 n-pentyl acetate 38.77 transcutol 185.37 n-heptanol 19.42 ethylbenzene 5.89 MIBK 31.23 2-propoxyethanol 179.78 tert-butanol 25.46 MTBE 16.94 2-butoxyethanol 111.52 propionic acid 143.05 o-xylene 8.34 formic acid 378.49 diethyl ether 29.88 m-xylene 8.82 p-xylene 5.98 chlorobenzene 28.7 dimethyl carbonate 93.76 n-octane 0.23 formamide 309.33 cyclopentanone 293.01 2-pentanone 71.47 anisole 27.08 cyclopentyl methyl ether 71.59 gamma-butyrolactone 413.15 1-methoxy-2-propanol 247.95 pyridine 139.34 3-pentanone 52.25 furfural 280.21 n-dodecane 0.18 diethylene glycol 151.78 diisopropyl ether 4.33 tert-amyl alcohol 24.48 acetylacetone 114.06 n-hexadecane 0.21 acetophenone 46.46 methyl propionate 100.83 isopentyl acetate 23.33 trichloroethylene 193.42 n-nonanol 14.47 cyclohexanol 29.21 benzyl alcohol 52.0 2-ethylhexanol 8.02 isooctanol 12.09 dipropyl ether 11.78 1,2-dichlorobenzene 26.84 ethyl lactate 43.18 propylene carbonate 149.56 n-methylformamide 338.55 2-pentanol 20.52 n-pentane 0.61 1-propoxy-2-propanol 77.6 1-methoxy-2-propyl acetate 71.79 2-(2-methoxypropoxy) propanol 60.77 mesitylene 3.47 ε-caprolactone 183.47 p-cymene 3.63 epichlorohydrin 347.41 1,1,1-trichloroethane 38.0 2-aminoethanol 171.09 morpholine-4-carbaldehyde 484.12 sulfolane 501.04 2,2,4-trimethylpentane 0.42 2-methyltetrahydrofuran 114.13 n-hexyl acetate 40.31 isooctane 0.22 2-(2-butoxyethoxy)ethanol 89.87 sec-butyl acetate 19.62 tert-butyl acetate 33.08 decalin 0.5 glycerin 193.03 diglyme 167.36 acrylic acid 193.94 isopropyl myristate 7.99 n-butyric acid 161.69 acetyl acetate 64.03 di(2-ethylhexyl) phthalate 19.94 ethyl propionate 32.7 nitromethane 526.72 1,2-diethoxyethane 31.19 benzonitrile 29.34 trioctyl phosphate 13.57 1-bromopropane 21.56 gamma-valerolactone 653.39 n-decanol 7.64 triethyl phosphate 15.78 4-methyl-2-pentanol 8.79 propionitrile 29.57 vinylene carbonate 162.82 1,1,2-trichlorotrifluoroethane 345.89 DMS 39.93 cumene 3.45 2-octanol 8.32 2-hexanone 32.08 octyl acetate 17.44 limonene 5.16 1,2-dimethoxyethane 135.67 ethyl orthosilicate 12.92 tributyl phosphate 12.27 diacetone alcohol 69.92 N,N-dimethylaniline 17.61 acrylonitrile 60.45 aniline 42.57 1,3-propanediol 181.69 bromobenzene 23.97 dibromomethane 63.61 1,1,2,2-tetrachloroethane 118.02 2-methyl-cyclohexyl acetate 20.83 tetrabutyl urea 18.67 diisobutyl methanol 3.44 2-phenylethanol 35.55 styrene 7.25 dioctyl adipate 20.86 dimethyl sulfate 187.2 ethyl butyrate 22.03 methyl lactate 130.12 butyl lactate 47.18 diethyl carbonate 14.95 propanediol butyl ether 96.01 triethyl orthoformate 19.28 p-tert-butyltoluene 3.44 methyl 4-tert-butylbenzoate 55.94 morpholine 237.53 tert-butylamine 6.32 n-dodecanol 4.03 dimethoxymethane 274.59 ethylene carbonate 116.57 cyrene 117.77 2-ethoxyethyl acetate 79.56 2-ethylhexyl acetate 16.64 1,2,4-trichlorobenzene 40.85 4-methylpyridine 96.09 dibutyl ether 6.95 2,6-dimethyl-4-heptanol 3.44 DEF 120.16 dimethyl isosorbide 100.82 tetrachloroethylene 81.51 eugenol 56.65 triacetin 72.44 span 80 60.51 1,4-butanediol 65.8 1,1-dichloroethane 44.33 2-methyl-1-pentanol 20.66 methyl formate 210.45 2-methyl-1-butanol 33.75 n-decane 0.44 butyronitrile 24.78 3,7-dimethyl-1-octanol 9.28 1-chlorooctane 3.76 1-chlorotetradecane 0.94 n-nonane 0.36 undecane 0.27 tert-butylcyclohexane 0.39 cyclooctane 0.28 cyclopentanol 69.26 tetrahydropyran 72.1 tert-amyl methyl ether 16.88 2,5,8-trioxanonane 91.06 1-hexene 2.82 2-isopropoxyethanol 88.05 2,2,2-trifluoroethanol 203.08 methyl butyrate 44.52 Scent© AI
| Maximum acceptable concentrations in the finished product (%) | |||
|---|---|---|---|
|
Category 1
Products applied to the lips
|
No restriction |
Category 7A
Rinse-off products applied to the hair with some hand contact
|
No restriction |
|
Category 2
Products applied to the axillae
|
No restriction |
Category 7B
Leave-on products applied to the hair with some hand contact
|
No restriction |
|
Category 3
Products applied to the face/body using fingertips
|
No restriction |
Category 8
Products with significant anogenital exposure
|
No restriction |
|
Category 4
Products related to fine fragrance
|
No restriction |
Category 9
Products with body and hand exposure, primarily rinse off
|
No restriction |
|
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
|
No restriction |
Category 10A
Household care products with mostly hand contact
|
No restriction |
|
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
|
No restriction |
Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
|
No restriction |
|
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
|
No restriction |
Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
|
No restriction |
|
Category 5D
Baby Creams, baby Oils and baby talc
|
No restriction |
Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
|
No restriction |
|
Category 6
Products with oral and lip exposure
|
No restriction |
Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
|
No restriction |